Potential of tumor-informed ctDNA as an early predictive indicator for relapse in advanced ovarian cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback